Bioxal-Soproper authorized in the EU: what beekeepers and distributors must do

Key data

Beekeepers and biocide distributors in Spain and throughout the European Union have had a single regulatory framework since April 10, 2026 for the use of Bioxal-Soproper. The Commission Implementing Regulation (EU) 2026/829, published on April 16, 2026, grants Union authorization for this biocide, eliminating the need for separate national authorizations in each Member State.

This is not a minor administrative procedure: it means that any operator in the chain—manufacturer, distributor or professional user—is bound by harmonized conditions of use, labeling and safety that are mandatory throughout Europe.

What does this regulation establish?

Commission Implementing Regulation (EU) 2026/829 grants a Union authorization for the single biocide Bioxal-Soproper, in accordance with Regulation (EU) No. 528/2012 of the European Parliament and of the Council, which regulates the placing on the market and use of biocides in the EU.

The key elements it establishes are:

• Centralized authorization: Bioxal-Soproper can be placed on the market and used in all Member States without the need for individual national authorizations.
• Active substance: Oxalic acid is the active substance of the product.
• Authorized use: Control of Varroa mite in beehives, in the field of beekeeping.
• Mandatory conditions: Operators must respect the conditions of use, labeling and safety defined in the regulation.
• Consequences of non-compliance: Sanctions and possible withdrawal of the product from the market.

Centralized authorization is the mechanism provided for in Regulation (EU) 528/2012 for products that can be placed on the market uniformly throughout the EU. Before this authorization, manufacturers had to manage national authorizations in each country where they wanted to operate, which involved different administrative costs and timelines by Member State.

Economic and operational impact

Single authorization has direct consequences for the operations of the chain actors:

• Manufacturers and authorization holders: Simplified access to the single European market with a single authorization file. The costs and times associated with processing national authorizations in each Member State are eliminated.
• Distributors: Can market the product throughout the EU under the same conditions, but must ensure that labeling and documentation comply with regulation requirements in each market.
• Beekeepers and professional users: Must verify that the product they purchase and use is authorized under this regulation and that they apply it in accordance with the conditions of use established. Use outside those conditions may result in sanctions.
• Risk of non-compliance: The regulation explicitly establishes that failure to comply with the conditions may result in sanctions and withdrawal of the product from the market, which would directly affect the availability of treatment for Varroa control.

Who does it affect?

• Bioxal-Soproper manufacturers: Holders of Union authorization, responsible for compliance with the conditions established in the regulation.
• Biocide distributors and wholesalers: Required to market the product in accordance with harmonized labeling and safety conditions.
• Professional and commercial beekeepers: Direct users of the product for treating beehives against Varroa mite.
• Advisors and bee health technicians: Must be aware of the current authorization framework to correctly guide their clients.
• Inspectors and competent authorities: Responsible for verifying compliance with regulation conditions throughout the chain.

Practical example

A professional beekeeper with 200 hives in Castilla y León who uses Bioxal-Soproper for Varroa control must verify the following as of April 10, 2026:

1. That the product he purchases from his distributor is marketed under the Union authorization granted by Regulation (EU) 2026/829, with labeling updated in accordance with the new harmonized conditions.
2. That he applies the product strictly according to the conditions of use established in that regulation (dosage, application method, safety conditions).
3. That he keeps documentation of the treatments carried out, as competent authorities may verify compliance during inspections.

If the distributor supplies him with the product without updated labeling or the beekeeper applies it outside the authorized conditions, both are exposed to sanctions and possible withdrawal of the product from the market, which would leave his hives without available treatment during the critical season.

What should companies do now?

1. Verify product authorization: Manufacturers and distributors must verify that Bioxal-Soproper they market is covered by the Union authorization of Regulation (EU) 2026/829, in force since April 10, 2026.
2. Review labeling: Update or verify that product labeling complies with the harmonized conditions established in the regulation. Incorrect labeling is grounds for sanctions and withdrawal.
3. Train professional users: Distributors and beekeeping advisors must ensure that beekeepers are aware of the authorized conditions of use to avoid incorrect applications.
4. Review treatment records: Beekeepers must maintain updated documentation of treatments carried out with Bioxal-Soproper, including dosage and dates, to demonstrate compliance in case of inspections.
5. Consult the complete regulation: Access the full text of Commission Implementing Regulation (EU) 2026/829 to learn all specific conditions of use, safety and labeling applicable.